Global Flow Cytometry in Oncology and Immunology Market Research Report 2023

Publication ID:

PB504230084

Publication Date:

June 6, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Flow cytometry is a powerful technology that is widely used in both oncology and immunology research. It is a technique used to analyze the physical and chemical properties of cells in a heterogeneous population, by labeling and detecting specific molecules on the surface of cells. The resulting data can provide information about the number, size, and complexity of cells in a sample, as well as their phenotype and function.
In oncology, flow cytometry is often used to analyze cancer cells and to monitor the progression of the disease. For example, flow cytometry can be used to identify and quantify cancer stem cells, which are thought to be responsible for tumor initiation and recurrence. It can also be used to measure the expression of tumor-associated antigens, which are molecules expressed by cancer cells that can be targeted by immunotherapy.
Overall, flow cytometry is a versatile tool that has many applications in oncology and immunology research. It can provide valuable information about the biology of cells and their interactions with other cells and molecules, and can help researchers to develop new diagnostic and therapeutic approaches for cancer and other diseases
According to QYResearch鈥檚 new survey, global Flow Cytometry in Oncology and Immunology market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Flow Cytometry in Oncology and Immunology 91制片厂.
The global increase in HIV diagnoses is a significant market factor for flow cytometry, and this is because the flow cytometry technique is specifically used for HIV diagnosis. In flow cytometry, light scattering is utilized to identify cells. These cells receive particular markers known as CDs depending on the type of scattering (clusters of differentiation). The main market players are concentrating on creating new products, which is anticipated to propel market growth over the forecast year.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Flow Cytometry in Oncology and Immunology market with multiple angles, which provides sufficient supports to readers鈥� strategy and decision making.
By Company
Agilent
ABYNTEK BIOPHARMA
Bio-Rad Laboratories
Cell Signaling Technology
Cytek Biosciences
Danaher Corporation,
DiaSorin S.p.A (Luminex Corporation),
Enzi Biochem Inc
Laboratory Corporation of America Holdings,
Merck KGaA
Miltenyi Biotec
NeoGenomics Laboratories
OPKO Health
Sony Group Corporation
Thermo Fisher Scientific Inc.
Segment by Type
Products
Services
Segment by Application
Immunology
Oncology
Solid Tumor
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Flow Cytometry in Oncology and Immunology report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies鈥� Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies鈥� Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Flow Cytometry in Oncology and Immunology Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Products
1.2.3 Services
1.3 Market by Application
1.3.1 Global Flow Cytometry in Oncology and Immunology Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Immunology
1.3.3 Oncology
1.3.4 Solid Tumor
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Flow Cytometry in Oncology and Immunology Market Perspective (2018-2029)
2.2 Flow Cytometry in Oncology and Immunology Growth Trends by Region
2.2.1 Global Flow Cytometry in Oncology and Immunology Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Flow Cytometry in Oncology and Immunology Historic Market Size by Region (2018-2023)
2.2.3 Flow Cytometry in Oncology and Immunology Forecasted Market Size by Region (2024-2029)
2.3 Flow Cytometry in Oncology and Immunology Market Dynamics
2.3.1 Flow Cytometry in Oncology and Immunology Industry Trends
2.3.2 Flow Cytometry in Oncology and Immunology Market Drivers
2.3.3 Flow Cytometry in Oncology and Immunology Market Challenges
2.3.4 Flow Cytometry in Oncology and Immunology Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Flow Cytometry in Oncology and Immunology Players by Revenue
3.1.1 Global Top Flow Cytometry in Oncology and Immunology Players by Revenue (2018-2023)
3.1.2 Global Flow Cytometry in Oncology and Immunology Revenue Market Share by Players (2018-2023)
3.2 Global Flow Cytometry in Oncology and Immunology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Flow Cytometry in Oncology and Immunology Revenue
3.4 Global Flow Cytometry in Oncology and Immunology Market Concentration Ratio
3.4.1 Global Flow Cytometry in Oncology and Immunology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Flow Cytometry in Oncology and Immunology Revenue in 2022
3.5 Flow Cytometry in Oncology and Immunology Key Players Head office and Area Served
3.6 Key Players Flow Cytometry in Oncology and Immunology Product Solution and Service
3.7 Date of Enter into Flow Cytometry in Oncology and Immunology Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Flow Cytometry in Oncology and Immunology Breakdown Data by Type
4.1 Global Flow Cytometry in Oncology and Immunology Historic Market Size by Type (2018-2023)
4.2 Global Flow Cytometry in Oncology and Immunology Forecasted Market Size by Type (2024-2029)
5 Flow Cytometry in Oncology and Immunology Breakdown Data by Application
5.1 Global Flow Cytometry in Oncology and Immunology Historic Market Size by Application (2018-2023)
5.2 Global Flow Cytometry in Oncology and Immunology Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Flow Cytometry in Oncology and Immunology Market Size (2018-2029)
6.2 North America Flow Cytometry in Oncology and Immunology Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Flow Cytometry in Oncology and Immunology Market Size by Country (2018-2023)
6.4 North America Flow Cytometry in Oncology and Immunology Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Flow Cytometry in Oncology and Immunology Market Size (2018-2029)
7.2 Europe Flow Cytometry in Oncology and Immunology Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Flow Cytometry in Oncology and Immunology Market Size by Country (2018-2023)
7.4 Europe Flow Cytometry in Oncology and Immunology Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Flow Cytometry in Oncology and Immunology Market Size (2018-2029)
8.2 Asia-Pacific Flow Cytometry in Oncology and Immunology Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Flow Cytometry in Oncology and Immunology Market Size by Region (2018-2023)
8.4 Asia-Pacific Flow Cytometry in Oncology and Immunology Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Flow Cytometry in Oncology and Immunology Market Size (2018-2029)
9.2 Latin America Flow Cytometry in Oncology and Immunology Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Flow Cytometry in Oncology and Immunology Market Size by Country (2018-2023)
9.4 Latin America Flow Cytometry in Oncology and Immunology Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Flow Cytometry in Oncology and Immunology Market Size (2018-2029)
10.2 Middle East & Africa Flow Cytometry in Oncology and Immunology Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Flow Cytometry in Oncology and Immunology Market Size by Country (2018-2023)
10.4 Middle East & Africa Flow Cytometry in Oncology and Immunology Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Agilent
11.1.1 Agilent Company Detail
11.1.2 Agilent Business Overview
11.1.3 Agilent Flow Cytometry in Oncology and Immunology Introduction
11.1.4 Agilent Revenue in Flow Cytometry in Oncology and Immunology Business (2018-2023)
11.1.5 Agilent Recent Development
11.2 ABYNTEK BIOPHARMA
11.2.1 ABYNTEK BIOPHARMA Company Detail
11.2.2 ABYNTEK BIOPHARMA Business Overview
11.2.3 ABYNTEK BIOPHARMA Flow Cytometry in Oncology and Immunology Introduction
11.2.4 ABYNTEK BIOPHARMA Revenue in Flow Cytometry in Oncology and Immunology Business (2018-2023)
11.2.5 ABYNTEK BIOPHARMA Recent Development
11.3 Bio-Rad Laboratories
11.3.1 Bio-Rad Laboratories Company Detail
11.3.2 Bio-Rad Laboratories Business Overview
11.3.3 Bio-Rad Laboratories Flow Cytometry in Oncology and Immunology Introduction
11.3.4 Bio-Rad Laboratories Revenue in Flow Cytometry in Oncology and Immunology Business (2018-2023)
11.3.5 Bio-Rad Laboratories Recent Development
11.4 Cell Signaling Technology
11.4.1 Cell Signaling Technology Company Detail
11.4.2 Cell Signaling Technology Business Overview
11.4.3 Cell Signaling Technology Flow Cytometry in Oncology and Immunology Introduction
11.4.4 Cell Signaling Technology Revenue in Flow Cytometry in Oncology and Immunology Business (2018-2023)
11.4.5 Cell Signaling Technology Recent Development
11.5 Cytek Biosciences
11.5.1 Cytek Biosciences Company Detail
11.5.2 Cytek Biosciences Business Overview
11.5.3 Cytek Biosciences Flow Cytometry in Oncology and Immunology Introduction
11.5.4 Cytek Biosciences Revenue in Flow Cytometry in Oncology and Immunology Business (2018-2023)
11.5.5 Cytek Biosciences Recent Development
11.6 Danaher Corporation,
11.6.1 Danaher Corporation, Company Detail
11.6.2 Danaher Corporation, Business Overview
11.6.3 Danaher Corporation, Flow Cytometry in Oncology and Immunology Introduction
11.6.4 Danaher Corporation, Revenue in Flow Cytometry in Oncology and Immunology Business (2018-2023)
11.6.5 Danaher Corporation, Recent Development
11.7 DiaSorin S.p.A (Luminex Corporation),
11.7.1 DiaSorin S.p.A (Luminex Corporation), Company Detail
11.7.2 DiaSorin S.p.A (Luminex Corporation), Business Overview
11.7.3 DiaSorin S.p.A (Luminex Corporation), Flow Cytometry in Oncology and Immunology Introduction
11.7.4 DiaSorin S.p.A (Luminex Corporation), Revenue in Flow Cytometry in Oncology and Immunology Business (2018-2023)
11.7.5 DiaSorin S.p.A (Luminex Corporation), Recent Development
11.8 Enzi Biochem Inc
11.8.1 Enzi Biochem Inc Company Detail
11.8.2 Enzi Biochem Inc Business Overview
11.8.3 Enzi Biochem Inc Flow Cytometry in Oncology and Immunology Introduction
11.8.4 Enzi Biochem Inc Revenue in Flow Cytometry in Oncology and Immunology Business (2018-2023)
11.8.5 Enzi Biochem Inc Recent Development
11.9 Laboratory Corporation of America Holdings,
11.9.1 Laboratory Corporation of America Holdings, Company Detail
11.9.2 Laboratory Corporation of America Holdings, Business Overview
11.9.3 Laboratory Corporation of America Holdings, Flow Cytometry in Oncology and Immunology Introduction
11.9.4 Laboratory Corporation of America Holdings, Revenue in Flow Cytometry in Oncology and Immunology Business (2018-2023)
11.9.5 Laboratory Corporation of America Holdings, Recent Development
11.10 Merck KGaA
11.10.1 Merck KGaA Company Detail
11.10.2 Merck KGaA Business Overview
11.10.3 Merck KGaA Flow Cytometry in Oncology and Immunology Introduction
11.10.4 Merck KGaA Revenue in Flow Cytometry in Oncology and Immunology Business (2018-2023)
11.10.5 Merck KGaA Recent Development
11.11 Miltenyi Biotec
11.11.1 Miltenyi Biotec Company Detail
11.11.2 Miltenyi Biotec Business Overview
11.11.3 Miltenyi Biotec Flow Cytometry in Oncology and Immunology Introduction
11.11.4 Miltenyi Biotec Revenue in Flow Cytometry in Oncology and Immunology Business (2018-2023)
11.11.5 Miltenyi Biotec Recent Development
11.12 NeoGenomics Laboratories
11.12.1 NeoGenomics Laboratories Company Detail
11.12.2 NeoGenomics Laboratories Business Overview
11.12.3 NeoGenomics Laboratories Flow Cytometry in Oncology and Immunology Introduction
11.12.4 NeoGenomics Laboratories Revenue in Flow Cytometry in Oncology and Immunology Business (2018-2023)
11.12.5 NeoGenomics Laboratories Recent Development
11.13 OPKO Health
11.13.1 OPKO Health Company Detail
11.13.2 OPKO Health Business Overview
11.13.3 OPKO Health Flow Cytometry in Oncology and Immunology Introduction
11.13.4 OPKO Health Revenue in Flow Cytometry in Oncology and Immunology Business (2018-2023)
11.13.5 OPKO Health Recent Development
11.14 Sony Group Corporation
11.14.1 Sony Group Corporation Company Detail
11.14.2 Sony Group Corporation Business Overview
11.14.3 Sony Group Corporation Flow Cytometry in Oncology and Immunology Introduction
11.14.4 Sony Group Corporation Revenue in Flow Cytometry in Oncology and Immunology Business (2018-2023)
11.14.5 Sony Group Corporation Recent Development
11.15 Thermo Fisher Scientific Inc.
11.15.1 Thermo Fisher Scientific Inc. Company Detail
11.15.2 Thermo Fisher Scientific Inc. Business Overview
11.15.3 Thermo Fisher Scientific Inc. Flow Cytometry in Oncology and Immunology Introduction
11.15.4 Thermo Fisher Scientific Inc. Revenue in Flow Cytometry in Oncology and Immunology Business (2018-2023)
11.15.5 Thermo Fisher Scientific Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Agilent
ABYNTEK BIOPHARMA
Bio-Rad Laboratories
Cell Signaling Technology
Cytek Biosciences
Danaher Corporation,
DiaSorin S.p.A (Luminex Corporation),
Enzi Biochem Inc
Laboratory Corporation of America Holdings,
Merck KGaA
Miltenyi Biotec
NeoGenomics Laboratories
OPKO Health
Sony Group Corporation
Thermo Fisher Scientific Inc.

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.